Pancreatic Cancer Research

ResearcherThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteNo recent work listed

Wendy L. Frankel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1658-1009; OpenAlex author ID A5061124226. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
47
Papers, trials and grants by year

2012: 2 papers · 2013: 2 papers · 2014: 2 papers · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper

Papers 10

  1. Morphologic changes associated with neoadjuvant-treated pancreatic ductal adenocarcinoma and comparison of two tumor regression grading systems. First author DOI 10.1016/j.humpath.2020.11.010↗
  2. Neoadjuvant-modified FOLFIRINOX vs nab-paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgic… Co-author DOI 10.1002/cam4.3075↗
  3. A microRNA-based signature predicts local-regional failure and overall survival after pancreatic cancer resection. Co-author DOI 10.18632/oncotarget.27496↗
  4. Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Tri… Co-author DOI 10.1001/jamasurg.2016.1137↗
  5. BMS-911543 inhibits viability of tumor and stromal cells and limits disease progression in genetically engineered mice with pancreatic cancer Co-author DOI 10.1186/2051-1426-2-s3-p186↗
  6. A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma. Co-author DOI 10.1245/s10434-013-3240-y↗
  7. Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner. Co-author DOI 10.1158/0008-5472.can-12-4601↗
  8. Genetically engineered murine pancreatic cancer models approximate immunophenotypic properties of human patients Co-author DOI 10.1186/2051-1426-1-s1-p163↗
  9. Osteopontin expression is associated with improved survival in patients with pancreatic adenocarcinoma. Co-author DOI 10.1245/s10434-012-2337-z↗
  10. The spectrum of hematologic malignancies involving the pancreas: potential clinical mimics of pancreatic adenocarcinoma. Last author DOI 10.1309/ajcpcxw7qug9efto↗

Closest collaborators

The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Adam R. Wolfe · 3 shared papers, 2020–2021 · strength 0.37
  2. Terence Marques Williams · 3 shared papers, 2020–2021 · strength 0.37
  3. Mark Bloomston · 6 shared papers, 2012–2014 · strength 0.23
  4. Wei Chen · 2 shared papers, 2020 · strength 0.20
  5. Mary E. Dillhoff · 2 shared papers, 2020 · strength 0.20
  6. Jennifer L. Vazzano · 1 shared paper, 2021 · strength 0.17
  7. Wei Chen · 1 shared paper, 2021 · strength 0.17
  8. Tanios Bekaii‐Saab · 4 shared papers, 2013–2016 · strength 0.15
  9. Amy Collins · 3 shared papers, 2012–2014 · strength 0.12
  10. Thomas A. Mace · 3 shared papers, 2013–2014 · strength 0.10
  11. Gregory B. Lesinski · 3 shared papers, 2013–2014 · strength 0.10
  12. Eric David Miller · 1 shared paper, 2020 · strength 0.10
  13. Jordan M. Cloyd · 1 shared paper, 2020 · strength 0.10
  14. Anne M. Noonan · 1 shared paper, 2020 · strength 0.10
  15. Laith I. Abushahin · 1 shared paper, 2020 · strength 0.10
  16. Steve Walston · 1 shared paper, 2020 · strength 0.10
  17. Nikhil Sebastian · 1 shared paper, 2020 · strength 0.10
  18. Patrick Wald · 1 shared paper, 2020 · strength 0.10
  19. Jin‐Young Jang · 1 shared paper, 2020 · strength 0.10
  20. Ryan N. Robb · 1 shared paper, 2020 · strength 0.10
  21. Wooil Kwon · 1 shared paper, 2020 · strength 0.10
  22. Jonathan B. Rock · 2 shared papers, 2012 · strength 0.08
  23. Thomas Ludwig · 2 shared papers, 2013–2014 · strength 0.07
  24. Timothy D. Eubank · 2 shared papers, 2013 · strength 0.07
  25. Matthew H. G. Katz · 1 shared paper, 2016 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.